Center-Authored Papers

Filters: Author is Bhatia, Shailender  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Tseng YD, Apisarnthanarax S, Liao JJ, Bhatia S, Nghiem PT, Parvathaneni U.  2017.  Factors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: A survey of US-based radiation oncologists.. Expert review of anticancer therapy. Abstract
S
Shah MH, Lorigan P, O'Brien MER, Fossella FV, Moore KN, Bhatia S, Kirby M, Woll PJ.  2016.  Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors.. Investigational new drugs. 34(3):290-299. Abstract
Santana-Davila R, Bhatia S, Chow LQM.  2016.  Harnessing the Immune System as a Therapeutic Tool in Virus-Associated Cancers.. JAMA oncology. Abstract
P
Paulson KG, Tegeder A, Willmes C, Iyer JG, Afanasiev OK, Schrama D, Koba S, Thibodeau R, Nagase K, Simonson WT et al..  2014.  Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.. Cancer immunology research. 2(11):1071-9. Abstract
Paulson KG, Lewis CW, Redman MW, Simonson WT, Lisberg A, Ritter D, Morishima C, Hutchinson K, Mudgistratova L, Blom A et al..  2016.  Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study.. Cancer. Abstract
Paulson KG, Iyer JG, Blom A, Warton ME, Sokil M, Yelistratova L, Schuman L, Nagase K, Bhatia S, Asgari MM et al..  2012.  Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma-Specific Survival Independent of Stage.. The Journal of investigative dermatology. Abstract
Pal SK, Azad AA, Bhatia S, Drabkin HA, Costello B, Sarantopoulos J, Kanesvaran R, Lauer R, Starodub AN, Hauke RJ et al..  2015.  A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC.. Clinical cancer research : an official journal of the American Association for Cancer Research. 21(15):3420-7. Abstract
N
Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Annamalai L, Berry S, Chartash EK, Daud A, Fling SP et al..  2016.  PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.. The New England journal of medicine. Abstract
M
Miller NJ, Bhatia S, Parvathaneni U, Iyer JG, Nghiem P.  2013.  Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma.. Current treatment options in oncology. 14(2):249-63. Abstract
L
Liao JJ, Parvathaneni U, Laramore GE, Thompson JA, Bhatia S, Futran ND, Bhrany AD, Hawes SE, Ladra M.  2014.  Fast neutron radiotherapy for primary mucosal melanomas of the head and neck.. Head & neck. 36(8):1162-7. Abstract
K
Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Linette GP, Milella M et al..  2016.  Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.. The Lancet. Oncology. Abstract
I
Iyer JG, Parvathaneni K, Bhatia S, Tarabadkar ES, Blom A, Doumani R, McKenzie J, Asgari MM, Nghiem P.  2016.  Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations.. Journal of the American Academy of Dermatology. Abstract
Iyer JG, Parvathaneni U, Gooley T, Miller NJ, Markowitz E, Blom A, Lewis CW, Doumani RF, Parvathaneni K, Anderson A et al..  2015.  Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma.. Cancer medicine. 4(8):1161-70. Abstract
Iyer JG, Blom A, Doumani R, Lewis C, Tarabadkar ES, Anderson A, Ma C, Bestick A, Parvathaneni U, Bhatia S et al..  2016.  Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma.. Cancer medicine. Abstract
G
Garcia JA, Hudes GR, Choueiri TK, Stadler WM, Wood LS, Gurtler J, Bhatia S, Joshi A, Hozak RR, Xu Y et al..  2014.  A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.. Cancer. 120(11):1647-55. Abstract
D
Daud A, Algazi A, Ashworth M, Buljan M, Takamura KT, Diep T, Pierce RH, Bhatia S.  2015.  Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100).. Journal of translational medicine. 13:2068.
C
Chapuis AG, Thompson JA, Margolin KA, Rodmyre R, Lai IP, Dowdy K, Farrar EA, Bhatia S, Sabath DE, Cao J et al..  2012.  Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.. Proceedings of the National Academy of Sciences of the United States of America. 109(12):4592-7. Abstract
Chapuis AG, Afanasiev OK, Iyer JG, Paulson KG, Parvathaneni U, Hwang JH, Lai I, Roberts IM, Sloan HL, Bhatia S et al..  2014.  Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.. Cancer immunology research. 2(1):27-36. Abstract
Chapuis AG, Roberts IM, Thompson JA, Margolin KA, Bhatia S, Lee SM, Sloan HL, Lai IP, Farrar EA, Wagener F et al..  2016.  T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(31):3787-3795. Abstract
Chapuis AG, Lee SM, Thompson JA, Roberts IM, Margolin KA, Bhatia S, Sloan HL, Lai I, Wagener F, Shibuya K et al..  2016.  Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.. The Journal of experimental medicine. 213(7):1133-9. Abstract
Chamberlain MC, Baik CS, Gadi VK, Bhatia S, Chow LQM.  2017.  Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.. Neuro-oncology. 19(1):i1-i24. Abstract
B
Brahmer JR, Tykodi SS, Chow LQM, Hwu W-J, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K et al..  2012.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.. The New England journal of medicine. 366(26):2455-65. Abstract
Blom A, Bhatia S, Pietromonaco S, Koehler K, Iyer JG, Nagase K, Paulson K, Sabath DE, Nghiem P.  2014.  Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma.. Journal of the American Academy of Dermatology. 70(3):449-55. Abstract
Bhatia S, Storer BE, Nghiem P.  2017.  Response.. Journal of the National Cancer Institute. 109(10)
Bhatia S, Curti B, Ernstoff MS, Gordon M, Heath EI, Miller WH, Puzanov I, Quinn DI, Flaig TW, VanVeldhuizen P et al..  2014.  Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study.. Journal for immunotherapy of cancer. 2:2. Abstract